[Diabetic polyneuropathy and ACE gene polymorphism].
Yasuda
Hitoshi
H
Department of Medicine, Shiga University of Medical Science.
D000804:Angiotensin II / Q000502:physiology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D002986:Clinical Trials as Topic; D003929:Diabetic Neuropathies / Q000188:drug therapy / Q000235:genetics*; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D007703:Peptidyl-Dipeptidase A / Q000235:genetics*; D010525:Peripheral Nerves / Q000378:metabolism; D011110:Polymorphism, Genetic; D000077583:Quinapril; D044140:Receptor, Angiotensin, Type 1 / Q000235:genetics / Q000378:metabolism; D044139:Receptor, Angiotensin, Type 2 / Q000378:metabolism; D044005:Tetrahydroisoquinolines / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D007211:Indoles; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D044005:Tetrahydroisoquinolines; D000804:Angiotensin II; C052035:trandolapril; D007703:Peptidyl-Dipeptidase A; D000077583:Quinapril